+ + + ITM’s subsidiary ITG Isotope Technologies Garching GmbH renamed as ITM Medical Isotopes GmbH + + +

+ + + ITM’s subsidiary ITG Isotope Technologies Garching GmbH renamed as ITM Medical Isotopes GmbH + + +

+ + + ITM’s subsidiary ITG Isotope Technologies Garching GmbH renamed as ITM Medical Isotopes GmbH + + +

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Newsticker


Inside Stories

Our Company

More

Pipeline

In Targeted Cancer Diagnostics & Therapy

Career

Be Part Of Our
Company

Targeted
Radionuclide
Therapy

  In Precision Oncology

Products

Radiopharmaceutical & Radioisotope Business

Diversity

Diversity at ITM

Trending


Neuroendocrine
Tumors
(GEP-NETs)

Glioblastoma

Osteosarcoma

Osteoblastic
Bone
Metastases
Folate
Receptor α+
Tumors

PIPELINE
UPDATE:

Innovative theranostic
candidates
in Precision
Oncology